These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19905898)

  • 1. Plausible--yes. But ..
    Fenton A; Panay N
    Climacteric; 2009 Dec; 12(6):461-2. PubMed ID: 19905898
    [No Abstract]   [Full Text] [Related]  

  • 2. Estrogen plus progestin, benefits and risks: the "Women's Health Initiative" trials.
    Keller KB; Lemberg L
    Am J Crit Care; 2005 Mar; 14(2):157-60. PubMed ID: 15728959
    [No Abstract]   [Full Text] [Related]  

  • 3. Hormone therapy and breast cancer: the press-release version of WHI study data.
    Pines A
    Climacteric; 2013 Apr; 16(2):222-5. PubMed ID: 23488525
    [No Abstract]   [Full Text] [Related]  

  • 4. From the challenge to the reassessment of the Women's Health Initiative: a personal initiative for women's health.
    Gambacciani M; Genazzani AR
    Gynecol Endocrinol; 2006 Mar; 22(3):115-6. PubMed ID: 16835071
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hormone replacement therapy and vessels: what's the story in 2007?].
    Chabbert-Buffet N
    J Mal Vasc; 2007 Dec; 32(4-5):190-1. PubMed ID: 17698308
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Breast cancer risk in relation to the interval between menopause and starting hormone therapy.
    Grant EC
    J Natl Cancer Inst; 2011 Jul; 103(13):1069; reply 1069-70. PubMed ID: 21700925
    [No Abstract]   [Full Text] [Related]  

  • 7. Hormone therapy. An update on risks and benefits.
    Mayo Clin Womens Healthsource; 2009 Mar; Suppl():1-8. PubMed ID: 19405167
    [No Abstract]   [Full Text] [Related]  

  • 8. A modern approach to postmenopausal HRT: trading bleeding with safety.
    Al-Azzawi F; Wahab M
    Womens Health (Lond); 2012 Jan; 8(1):1-4. PubMed ID: 22171766
    [No Abstract]   [Full Text] [Related]  

  • 9. [Increased risk of breast cancer following hormone replacement therapy during climacteric. 3 440 extra cases might have been caused by the treatment in Sweden during the 1990s].
    Magnusson C; Reeves G
    Lakartidningen; 2005 Apr 18-24; 102(16):1228-30. PubMed ID: 15921095
    [No Abstract]   [Full Text] [Related]  

  • 10. Estrogen-progestin increases breast cancer risk.
    Stephens MB
    J Fam Pract; 2000 Apr; 49(4):301-2. PubMed ID: 10778832
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical pharmacology and differential cognitive efficacy of estrogen preparations.
    Gleason CE; Carlsson CM; Johnson S; Atwood C; Asthana S
    Ann N Y Acad Sci; 2005 Jun; 1052():93-115. PubMed ID: 16024754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for hormone treatment of women in the menopausal transition and beyond.
    Naftolin F; Schneider HP; Sturdee DW;
    Maturitas; 2005 May; 51(1):15-20. PubMed ID: 15883104
    [No Abstract]   [Full Text] [Related]  

  • 13. Menopausal muddle.
    Park A; Sifferlin A
    Time; 2013 Aug; 182(6):12. PubMed ID: 24044163
    [No Abstract]   [Full Text] [Related]  

  • 14. HRT, HERS, NIH, WHI: alphabet soup?
    Legato MJ
    J Gend Specif Med; 2002; 5(6):10-3. PubMed ID: 12503220
    [No Abstract]   [Full Text] [Related]  

  • 15. Re-think HRT: behind the scene of perceptions.
    Pines A
    Climacteric; 2008; 11(6):443-6. PubMed ID: 18991073
    [No Abstract]   [Full Text] [Related]  

  • 16. Reducing the problems of the progestogen.
    Sturdee DW; MacLennan AH
    Climacteric; 2006 Aug; 9(4):241-3. PubMed ID: 16857653
    [No Abstract]   [Full Text] [Related]  

  • 17. Observational studies and clinical trials of menopausal hormone therapy: can they both be right?
    Allison MA; Manson JE
    Menopause; 2006; 13(1):1-3. PubMed ID: 16607089
    [No Abstract]   [Full Text] [Related]  

  • 18. Postmenopausal estrogens--opposed, unopposed, or none of the above.
    Willett WC; Colditz G; Stampfer M
    JAMA; 2000 Jan; 283(4):534-5. PubMed ID: 10659883
    [No Abstract]   [Full Text] [Related]  

  • 19. Estrogen and progestogen use in peri- and postmenopausal women: September 2003 position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2003; 10(6):497-506. PubMed ID: 14627857
    [No Abstract]   [Full Text] [Related]  

  • 20. The World Health Organization defines hormone replacement therapy as carcinogenic: is this plausible?
    Mueck AO; Seeger H
    Gynecol Endocrinol; 2008 Mar; 24(3):129-32. PubMed ID: 18335326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.